Skip to main content
Premium Trial:

Request an Annual Quote

Steve Lincoln, Mike Lelivelt, Greg Fisher, Robert Gentleman

Steve Lincoln has left his position as vice president of informatics at Affymetrix. In addition, Michael Lelivelt, previously senior manager for informatics applications at Affymetrix, has joined Partek as vide president of genomics.
An Affymetrix spokesman said that Greg Fisher, associate director of product marketing for systems and software, is taking on their responsibilities.

Bioinformatics.Org said this week that it will present the 2008 Benjamin Franklin Award in the Life Sciences to Robert Gentleman of the Fred Hutchinson Cancer Research Center. Gentleman is being recognized for his role in developing the open source statistical analysis package R and his role in developing BioConductor, an open source suite of tools for genomic data analysis. 
Members of Bioinformatics.Org, an open source bioinformatics advocacy group that now includes more than 24,000 members, vote for the recipient of the Franklin Award each year.
The award is presented annually to an individual “who has, in his or her practice, promoted free and open access to the materials and methods used in the life sciences.”

Filed under

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.